Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
AbbVie Inc. (ABBV) had Normalized Pre-Tax Income of $2.67B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$16.62B |
|
$1.82B |
|
$4.55B |
|
$12.07B |
|
$12.07B |
|
$4.54B |
|
$-1.88B |
|
$2.67B |
|
|
Normalized Pre-Tax Income |
$2.67B |
$1.81B |
|
$1.81B |
|
$1.81B |
|
$1.81B |
|
$4.54B |
|
-- |
|
-- |
|
1.77B |
|
-- |
|
$1.02 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|